Insperity (NSP) Competitors $53.01 -1.11 (-2.05%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$52.97 -0.04 (-0.07%) As of 09/12/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NSP vs. CCRN, KFY, RHI, ASGN, MAN, BBSI, HSII, KFRC, KELYA, and TBIShould you be buying Insperity stock or one of its competitors? The main competitors of Insperity include Cross Country Healthcare (CCRN), Korn/Ferry International (KFY), Robert Half (RHI), ASGN (ASGN), ManpowerGroup (MAN), Barrett Business Services (BBSI), Heidrick & Struggles International (HSII), Kforce (KFRC), Kelly Services (KELYA), and TrueBlue (TBI). Insperity vs. Its Competitors Cross Country Healthcare Korn/Ferry International Robert Half ASGN ManpowerGroup Barrett Business Services Heidrick & Struggles International Kforce Kelly Services TrueBlue Insperity (NYSE:NSP) and Cross Country Healthcare (NASDAQ:CCRN) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations. Do institutionals & insiders have more ownership in NSP or CCRN? 93.4% of Insperity shares are held by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are held by institutional investors. 5.3% of Insperity shares are held by insiders. Comparatively, 4.9% of Cross Country Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, NSP or CCRN? Insperity has a beta of 0.48, indicating that its stock price is 52% less volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500. Is NSP or CCRN more profitable? Insperity has a net margin of 0.60% compared to Cross Country Healthcare's net margin of -0.70%. Insperity's return on equity of 35.32% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Insperity0.60% 35.32% 1.84% Cross Country Healthcare -0.70%1.72%1.24% Does the media favor NSP or CCRN? In the previous week, Insperity had 5 more articles in the media than Cross Country Healthcare. MarketBeat recorded 9 mentions for Insperity and 4 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 1.23 beat Insperity's score of 0.51 indicating that Cross Country Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Insperity 2 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cross Country Healthcare 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate NSP or CCRN? Insperity currently has a consensus price target of $58.33, suggesting a potential upside of 10.04%. Cross Country Healthcare has a consensus price target of $17.93, suggesting a potential upside of 42.87%. Given Cross Country Healthcare's higher probable upside, analysts plainly believe Cross Country Healthcare is more favorable than Insperity.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Insperity 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Cross Country Healthcare 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has better earnings and valuation, NSP or CCRN? Insperity has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Insperity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInsperity$6.70B0.30$91M$1.0650.01Cross Country Healthcare$1.19B0.34-$14.56M-$0.26-48.27 SummaryInsperity beats Cross Country Healthcare on 11 of the 15 factors compared between the two stocks. Get Insperity News Delivered to You Automatically Sign up to receive the latest news and ratings for NSP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NSP vs. The Competition Export to ExcelMetricInsperityStaffing IndustryBusiness SectorNYSE ExchangeMarket Cap$2.00B$1.44B$26.48B$21.49BDividend Yield4.43%3.43%2.73%3.49%P/E Ratio50.0124.5527.0029.75Price / Sales0.304.23814.0051.60Price / Cash14.668.2725.8718.13Price / Book20.473.597.794.63Net Income$91M$30.46M$199.52M$999.94M7 Day Performance-0.29%3.19%6.72%0.62%1 Month Performance3.67%9.47%20.60%4.34%1 Year Performance-40.09%-19.62%51.47%16.38% Insperity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NSPInsperity4.6269 of 5 stars$53.01-2.1%$58.33+10.0%-40.1%$2.00B$6.70B50.014,500Analyst UpgradeCCRNCross Country Healthcare3.8938 of 5 stars$14.05-0.4%$17.93+27.6%-11.4%$461.94M$1.34B-54.048,205Positive NewsKFYKorn/Ferry International4.5044 of 5 stars$72.62-0.8%$81.00+11.5%+0.6%$3.83B$2.76B15.729,253Trending NewsEarnings ReportDividend AnnouncementHigh Trading VolumeRHIRobert Half4.9194 of 5 stars$35.94-3.0%$45.83+27.5%-43.8%$3.77B$5.80B20.5414,700Positive NewsASGNASGN3.4523 of 5 stars$52.49-1.1%$61.67+17.5%-44.5%$2.33B$4.10B16.613,200MANManpowerGroup4.5968 of 5 stars$38.43-6.9%$48.20+25.4%-46.2%$1.91B$17.85B-101.1226,700High Trading VolumeBBSIBarrett Business Services4.5665 of 5 stars$47.60-1.1%$47.00-1.3%+26.8%$1.24B$1.20B23.453,658HSIIHeidrick & Struggles International3.2681 of 5 stars$50.27-0.2%$51.00+1.5%+33.0%$1.04B$1.12B31.622,201Short Interest ↓KFRCKforce4.2786 of 5 stars$30.95-3.7%$52.33+69.1%-51.3%$597.59M$1.36B11.5512,000Ex-DividendKELYAKelly Services4.6165 of 5 stars$13.65-1.6%$25.00+83.2%-35.5%$488.95M$4.50B-68.254,200News CoverageAnalyst ForecastTBITrueBlue3.2833 of 5 stars$5.82-0.8%$8.00+37.6%-22.3%$175.22M$1.53B-5.064,200 Related Companies and Tools Related Companies CCRN Competitors KFY Competitors RHI Competitors ASGN Competitors MAN Competitors BBSI Competitors HSII Competitors KFRC Competitors KELYA Competitors TBI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NSP) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insperity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Insperity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NSP Stock Alerts